Skip to main content
Senzime logo

Senzime — Investor Relations & Filings

Ticker · SEZI ISIN · SE0002478776 LEI · 549300JQF174JP0MM382 ST Manufacturing
Open in API
Filings indexed 216 across all filing types
Latest filing 2023-02-16 Capital/Financing Update
Country SE Sweden
Listing ST SEZI

About Senzime

https://senzime.com/en

Senzime is a medical device company that develops and markets precision-based patient monitoring solutions designed to enhance patient safety. The company's primary focus is on systems for neuromuscular and respiratory monitoring during and after surgery. Its flagship product, the TetraGraph, is an algorithm-powered monitor that provides quantitative train-of-four (TOF) monitoring based on electromyography (EMG) technology. This enables clinicians to precisely manage neuromuscular blockade, reduce postoperative complications, and improve patient outcomes. Senzime's technology supports the adoption of new clinical guidelines, aiming to establish a higher standard of care in anesthesia and recovery.

Recent filings

Filing Released Lang Actions
Senzime publishes prospectus relating to the rights issue
Capital/Financing Update Classification · 1% confidence The document is a press release announcing that Senzime has published a prospectus related to a rights issue (a form of capital raising/share issue). The text explicitly mentions the approval and registration of the prospectus by the Swedish Financial Supervisory Authority and directs readers to the prospectus for investment details. Since the document itself is an announcement about the publication of a capital-raising document (the prospectus), and it details financing activities (Rights Issue, loan, credit facilities), it strongly relates to capital structure changes and fundraising. The most fitting category is 'Capital/Financing Update' (CAP). While it mentions a prospectus, the primary focus is the financing event itself, not just the announcement of a report (RPA) or a general regulatory filing (RNS). The core subject is the Rights Issue, which falls under CAP.
2023-02-16 English
Bulletin from Extraordinary General Meeting in Senzime AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Bulletin from Extraordinary General Meeting in Senzime AB (publ)' and details resolutions passed at this meeting, specifically concerning a 'new issue of shares with preferential rights for existing shareholders.' This content directly relates to shareholder voting outcomes and decisions made at a general meeting. Therefore, the most appropriate classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it involves a share issue (CAP/SHA), the context is the formal announcement of the EGM's resolution on that issue, making DVA the primary fit.
2023-02-16 English
Kommuniké från extra bolagsstämma i Senzime AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is titled "Kommuniké från extra bolagsstämma i Senzime AB (publ)" (Communiqué from the Extraordinary General Meeting in Senzime AB (publ)). It details decisions made at an Extraordinary General Meeting (EGM), specifically approving a rights issue (nyemission). While it relates to a shareholder meeting, the core content is the decision regarding a capital change (the rights issue). The closest specific category for capital structure changes involving share issuance is 'Share Issue/Capital Change' (SHA). However, the document explicitly reports the *results* and *decisions* made at a general meeting, which aligns strongly with the context of shareholder voting and meeting outcomes. Since the document is a formal announcement summarizing the decisions of an EGM, and it involves a major capital action, it touches upon both CAP and DVA/AGM-R themes. Given the context of reporting the *decisions* made at the EGM, and the fact that the primary action approved is a share issuance, 'CAP' (Capital/Financing Update) is highly relevant, but 'AGM-R' (AGM Information) covers the meeting itself. Since the document is a formal communiqué *from* the EGM detailing the outcome, and the outcome is a major financing event, 'CAP' is the most specific financial action described. However, if we strictly follow the definitions, the document is the official record of decisions from a general meeting. Since the decisions directly concern a share issue, 'CAP' is a strong fit. Let's re-evaluate: The document is a 'Communiqué from EGM'. This points towards AGM-R or DVA (Declaration of Voting Results). Since it details the *decisions* made, and one major decision is a share issue, 'CAP' is the subject matter. Given the options, and the focus on the capital action (nyemission), 'CAP' is selected as the primary financial event being communicated, although it originates from an EGM. If the document were only the voting results without the specific financial details, DVA would be better. Since it details the terms of the share issue, CAP is appropriate. The document length is short (2769 chars) and it is a press release announcing the outcome, not the full minutes or presentation, making it an announcement type, but CAP is a content type. I will classify it as CAP because the core news is the rights issue approval.
2023-02-16 Swedish
Senzime vinner ny stor order för sin barnsensor i USA
Regulatory Filings Classification · 1% confidence The document is a 'PRESSMEDDELANDE' (Press Release) dated February 1, 2023, announcing a significant new order win for the company's pediatric sensor system in the USA. It details the order size (over 2 million SEK annually) and provides background on the technology (TetraGraph/TetraSens) and recent regulatory milestones (ASA guidelines, FDA approval). Crucially, the document ends with a section titled 'Bifogade filer' (Attached files) which links to the full PDF of the announcement. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of information, rather than being the comprehensive report itself, should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since this is a specific announcement about a business event (a major order win) released via a press release format, it fits best as a general Regulatory Filing (RNS) or potentially an announcement of news that doesn't fit other specific categories. Given the context of a press release announcing news, RNS is the most appropriate fallback for non-standard corporate news announcements that aren't earnings, management changes, or capital structure events.
2023-02-01 Swedish
Senzime wins large order for its pediatric sensor in the US
Regulatory Filings Classification · 1% confidence The document is a press release dated February 1, 2023, announcing a large order win for the company's product in the US. It details the order size, product information (TetraGraph, TetraSens), regulatory clearances (FDA), and includes contact information for Investor Relations (IR). The final line states: "This information is information that Senzime is obliged to make public pursuant to the EU Market Abuse Regulation." This strongly suggests a mandatory regulatory disclosure. Since it is a general announcement of business news that doesn't fit specific categories like Earnings Release (ER), Capital (CAP), or Director's Dealing (DIRS), and it is not an announcement of a report publication (RPA), the most appropriate general category for mandatory, non-specific regulatory disclosures under EU regulations is Regulatory Filings (RNS).
2023-02-01 English
Earnings Release 2022
Earnings Release Classification · 1% confidence The document provides a detailed summary of financial results for the period January - December 2022, including specific figures for Q4 2022 and the full year, comparing them to the previous year (2021). It includes key financial metrics like Net Sales (Nettoomsättning), Gross Margin (Bruttomarginal), Operating Result (Rörelseresultat), and Earnings Per Share (Resultat per aktie). It also discusses events after the quarter's end, such as a rights issue (företrädesemission) and management commentary on strategy and performance. The structure, content (quarterly and annual financial performance), and inclusion of comparative figures strongly indicate this is a comprehensive financial report covering a period shorter than a full year, or a year-end report that is not the full 10-K filing. Since it covers a full year (Jan-Dec 2022) but is presented in a format typical of an interim/year-end earnings report rather than the extensive regulatory 10-K, the most appropriate classification is Interim / Quarterly Report (IR), as it summarizes the full year's performance in detail, often preceding or supplementing the 10-K. Given the Swedish context and the detailed financial breakdown, it functions as the primary annual financial disclosure for investors, fitting the 'IR' category for comprehensive period reporting. Q4 2022
2023-02-01 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.